Sanofi (SASY.PA) has entered into an agreement to acquire Dren Bio’s immunology unit, securing rights to its autoimmune disease treatment, DR-0201.
As part of the deal, the French pharmaceutical giant will…
Eli Lilly (LLY.N) has officially launched its blockbuster diabetes and weight-loss drug, Mounjaro, in India after securing approval from the country’s drug regulator. The move presents a significant market opportunity…
Priscilla Chan, co-founder of the Chan Zuckerberg Initiative (CZI), envisions a future where artificial intelligence (AI) transforms medical research, enabling the early detection and prevention of diseases within the next…
Generative artificial intelligence (GenAI) is no longer a distant innovation but a transformative force reshaping the healthcare sector. With promising early outcomes, healthcare organizations are rapidly scaling their investments in…
e& enterprise, the digital transformation division of e&, has formed a strategic alliance with AI-powered healthcare solutions provider RAIN Technology to revolutionize healthcare delivery across the Middle East and Africa…
Mobihealth International has partnered with Airtel to enhance access to affordable digital healthcare services across Africa. This collaboration aims to bridge healthcare gaps by leveraging telemedicine technology to connect users…
Global pharmaceutical giant Pfizer (PFE.N) has completed the sale of its entire stake in consumer healthcare firm Haleon (HLN.L) for approximately £2.5 billion ($3.24 billion). The transaction, conducted at 385…
Oman has successfully localized nine major health sector projects within Khazaen Economic City, South Al Batinah Governorate, with a total investment value of OMR 156 million (approximately $405 million) by…
Swiss pharmaceutical giant Roche (ROG.S) has secured the rights to Zealand Pharma’s (ZELA.CO) obesity treatment candidate, petrelintide, in a strategic collaboration valued at up to $5.3 billion. This deal marks…